New and emerging viruses and arboviruses represent increasing threats to human health, yet their mechanisms of emergence remain poorly understood, and effective interventions are not available for most. Research on their ecology, evolution, epidemiology, emergence mechanisms, diagnostics, and development of vaccines and therapeutics remain critical public health needs. The World Reference Center for Emerging Viruses and Arboviruses (WRCEVA) comprises a comprehensive, diverse collection of over 6,700 virus strains in 21 families, as well as antisera, antigens and other reagents to enable research worldwide. Approximately 400 new virus strains are added each year, and 1000 viruses and reagents are shipped annually. The WRCEVA also maintains broad expertise in both novel and traditional approaches to virus identification and characterization, and assists with outbreak diagnosis. This proposal seeks to continue these WRCEVA activities in support of NIH-funded and other research on emerging viruses worldwide through 5 Specific Aims: 1. Maintain a comprehensive set of emerging viruses, arboviruses and associated reagents to support research and surveillance. The virus collection as well as antigens, antibodies and other reagents will be continually enhanced to capitalize on new technology, and cDNA clones of selected strains will be added. NextGen sequencing-based quality control practices will be implemented to ensure strain accuracy/purity. 2. Discover, isolate and characterize newly acquired viruses by using electron microscopy, next generation sequencing, and serologic methods to determine relationships and taxonomic assignments, and to assess in vitro and in vivo host range. Clinical and field samples as well as viral isolates will be received for identification and characterization, and added to the repository. Critical phenotypes of newly discovered viruses and strains will be assessed by using in vitro and in vivo infections. 3. Perform sequencing and phylogenetic analyses of selected virus groups to determine evolutionary histories and emergence mechanisms, patterns of spread and infection, and to rapidly determine the sources of new outbreaks. Key virus strains will undergo genomic sequencing to generate databases that can be exploited for the rapid determination of new outbreak sources, including potential bioterrorism. 4. Characterize recently discovered mosquito-specific viruses (MSVs) and determine their evolutionary history, impact on the transmission of arboviruses, and genetic determinants of host range. Selected arbovirus taxa that include mosquito-specific viruses will be studied to understand the genetic basis of their host range restriction and assess their potential as tools to interfere with arbovirus transmission 5. Train scientists in the identification and characterization of emerging viruses and arboviruses. To further enhance research efforts in the U.S. and worldwide as well as to leverage collaborations that feed our collections, basic training in virus identification and characterizaton will be provided to qualified scientists.

Public Health Relevance

Research on emerging viruses and arthropod-borne viruses requires diverse collections of virus strains as well as antibodies, antigens and other reagents that cannot be made at many scientific institutions. The World Reference Center for Emerging Viruses and Arboviruses (WRCEVA), established over 5 decades ago, maintains a comprehensive, diverse collection of over 6,700 virus strains in 21 families, as well as related reagents to enable emerging virus research worldwide.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Resource-Related Research Projects (R24)
Project #
5R24AI120942-03
Application #
9418023
Study Section
Special Emphasis Panel (ZAI1)
Program Officer
Repik, Patricia M
Project Start
2016-02-01
Project End
2021-01-31
Budget Start
2018-02-01
Budget End
2019-01-31
Support Year
3
Fiscal Year
2018
Total Cost
Indirect Cost
Name
University of Texas Med Br Galveston
Department
Pathology
Type
Schools of Medicine
DUNS #
800771149
City
Galveston
State
TX
Country
United States
Zip Code
77555
Xie, Xuping; Yang, Yujiao; Muruato, Antonio E et al. (2017) Understanding Zika Virus Stability and Developing a Chimeric Vaccine through Functional Analysis. MBio 8:
Sadeghi, Mohammadreza; Popov, Vsevolod; Guzman, Hilda et al. (2017) Genomes of viral isolates derived from different mosquitos species. Virus Res 242:49-57
Erasmus, Jesse H; Auguste, Albert J; Kaelber, Jason T et al. (2017) A chikungunya fever vaccine utilizing an insect-specific virus platform. Nat Med 23:192-199
Roundy, Christopher M; Azar, Sasha R; Rossi, Shannan L et al. (2017) Variation in Aedes aegypti Mosquito Competence for Zika Virus Transmission. Emerg Infect Dis 23:625-632
Contreras, Maria Angelica; Eastwood, Gillian; Guzman, Hilda et al. (2017) Almendravirus: A Proposed New Genus of Rhabdoviruses Isolated from Mosquitoes in Tropical Regions of the Americas. Am J Trop Med Hyg 96:100-109
Hart, Charles E; Roundy, Christopher M; Azar, Sasha R et al. (2017) Zika Virus Vector Competency of Mosquitoes, Gulf Coast, United States. Emerg Infect Dis 23:559-560
McGrath, Erica L; Rossi, Shannan L; Gao, Junling et al. (2017) Differential Responses of Human Fetal Brain Neural Stem Cells to Zika Virus Infection. Stem Cell Reports 8:715-727
Shan, Chao; Muruato, Antonio E; Jagger, Brett W et al. (2017) A single-dose live-attenuated vaccine prevents Zika virus pregnancy transmission and testis damage. Nat Commun 8:676
Vinhaes, Eriko S; Santos, Luciane A; Dias, Lislane et al. (2017) Transient Hearing Loss in Adults Associated With Zika Virus Infection. Clin Infect Dis 64:675-677
Fontes-Garfias, Camila R; Shan, Chao; Luo, Huanle et al. (2017) Functional Analysis of Glycosylation of Zika Virus Envelope Protein. Cell Rep 21:1180-1190

Showing the most recent 10 out of 46 publications